New eye Drug's Real-World impact under the microscope
NCT ID NCT06075147
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study looks at how well the eye injection aflibercept 8 mg works for people with vision loss from age-related macular degeneration (nAMD) or diabetic macular edema (DME). Researchers will collect data from 2500 adults already prescribed the drug by their doctors, tracking vision changes over 12 to 24 months. No extra visits or tests are required—only routine care information is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VISUAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Australia
-
Many Locations
Multiple Locations, Canada
-
Many Locations
Multiple Locations, Denmark
-
Many Locations
Multiple Locations, Finland
-
Many Locations
Multiple Locations, France
-
Many Locations
Multiple Locations, Germany
-
Many Locations
Multiple Locations, Italy
-
Many Locations
Multiple Locations, Japan
-
Many Locations
Multiple Locations, Netherlands
-
Many Locations
Multiple Locations, Norway
-
Many Locations
Multiple Locations, Portugal
-
Many Locations
Multiple Locations, Saudi Arabia
-
Many Locations
Multiple Locations, South Korea
-
Many Locations
Multiple Locations, Spain
-
Many Locations
Multiple Locations, Sweden
-
Many Locations
Multiple Locations, Switzerland
-
Many Locations
Multiple Locations, United Arab Emirates
-
Many Locations
Multiple Locations, United Kingdom
Conditions
Explore the condition pages connected to this study.